Skip to main navigation Skip to search Skip to main content

Neue systemische Therapieansätze bei malignen Augenlidtumoren

Translated title of the contribution: New systemic treatment approaches for malignant eyelid tumors
  • Prof. Ludwig Heindl, Zentrum für Augenheilkunde, Universität Köln
  • Centrum für Integrierte Onkologie (CIO) Aachen - Köln - Bonn - Düsseldorf

Research output: Contribution to journal › Review article › peer-review

1 Citation (Web of Science)

Abstract

Malignant tumors of the eyelids represent a diagnostic and therapeutic challenge. Modern treatment approaches, such as targeted treatment and immunotherapy are becoming increasingly more important, particularly in advanced and metastatic stages; however, these can cause side effects such as fatigue, skin reactions and gastrointestinal complaints, which require close monitoring. An effective treatment option for advanced, metastasized or inoperable basal cell carcinoma is the well-manageable oral treatment with hedgehog inhibitors; however, these innovative, systemic treatment approaches require an individually adapted management, which is determined by an interdisciplinary tumor board and accompanied by a specialized, multiprofessional team to ensure optimal patient care.

Translated title of the contributionNew systemic treatment approaches for malignant eyelid tumors
Original languageGerman
Pages (from-to)342-348
Number of pages7
JournalOPHTHALMOLOGIE
Volume122
Issue number5
Early online dateApr 2025
DOIs
Publication statusPublished - May 2025

Fingerprint

Dive into the research topics of 'New systemic treatment approaches for malignant eyelid tumors'. Together they form a unique fingerprint.

Cite this